qualifications: Director and Research Professor, Institute
for Arteriosclerosis Research, Loma Linda University, School
Heart Disease and the Mucopolysaccharides (1974, Charles
1982 Dr. Morrison wrote: "I am Lester Morrison MD,
and I have been a doctor for over 50 years. Much of that
time has been devoted to finding a way to stop heart disease,
which killed my mother, my father and several other members
of my family and remains the number one killer in the U.S.
and other developed countries."
Morrison provided compelling evidence in the 1960s that
heart and blood vessel disease could be reversed and prevented
with natural molecules, particularly chondroitin sulfate.
This was over 20 years prior to the advent of the first
cholesterol-reducing statin drug, Mevacor (1987).
Morrison writes that his ideas involving heart disease went
back as far as 1942. He first began is his research using
natural molecules to heal damaged hearts and arteries.
Morrison’s research was published in no less than 8 different
medical journals. He began his studies in the 1940s, working
with choline, a natural component of lecithin.
are the results (below) of an early study published in the
Heart Journal. Lecithin was later to become an important
component in Dr.
Morrison’s Heart Saver Program. (Dr. Morrison’s book
for the lay public by this title can still be purchased.)
of Survival Rates: Choline (Lecithin)
with coronary thrombosis (blood clots in the heart)
after 3 years
patients Deaths with choline
patients Deaths without choline
American Heart Journal, JulyAugust, p. 729,
later conceived of the idea that gelatinous material, then
known as mucopolysaccharides, today known as glycosaminoglycans,
could heal damaged hearts and arteries. His work involved
chondroitin sulfate, a molecule that is a normal component
of the connective tissue in the body. Dr. Morrison calls
it "the glue of life."
noted that chondroitin is the "coronary artery’s
first line of defense against invasion by foreign substances,"
such as cholesterol, bacteria and tumor cells. Chondroitin
contributes to the elasticity of the blood vessels.
is often administered to fresh heart attack patients to
inhibit blood clots. The above photos demonstrate the superiority
of chondroitin sulfate over heparin. Dr. Morrison said,
"chondroitin did the job just as well as heparin,
and the effect lasted longer. The anti-clotting property
of heparin only lasts about 5 hours. In animal studies,
chondroitin prolonged anti-clotting for up to two full days."
was time for Dr. Morrison to begin treating live human subjects
with chondroitin. Here are the startling results of his
OF CHONDROITIN – HEART ATTACK PREVENTION
attacks among patients over 6-year period
Volume 25, Page 269, 1973
Total Risk Reduction
Morrison treated 134 patients with chondroitin between
1942 and 1955
results were more than good, they were marvelous."
1: coronary arteriosclerotic heart disease
2: arteriosclerosis of the brain arteries
3: hardening of the arteries of the legs
recent studies confirm Dr. Morrison’s earlier findings,
sulfate is important in healing following a heart attack.
Yet nothing is said of Dr. Morrison’s incredible discoveries
evidence is also provided by Dr. Morrison with the presentation
of individual cases, treated with chondroitin sulfate. Here
is the data presented in three individual subjects.
heart attack 1949
in 1965: artery disease, high blood pressure, coronary artery
cerebro-vascular incidents (impairment of oxygen to the
brain, "mini strokes"); visual impairment;
disorientation; exhaustion; difficulty speaking; needs assistance
to walk or stand; severe vertigo (imbalance); fainting (black
outs); blood pressure 170/125; takes 5 drugs and a vitamin
10,000 milligrams of oral chondroitin sulfate in May, 1966,
tapered to 3000 mgs after 4 months and 1500 mgs after 5
months. After 2 months, "dramatic persistent improvement
noted." All black-outs ceased; remarkable improvement
in vision; able to walk without assistance; able to walk
6 miles each morning; notable hair growth.
in 1966: coronary artery disease with angina (chest pain);
rheumatoid and osteoarthritis
pain radiating to right shoulder for 3 years accompanied
by shortness of breath, exhaustion, fright; symptoms relieved
by rest; blood pressure 118/74; ankle swelling. Takes vitamin
E, lecithin, valium, nitroglycerine, multivitamin, thyroid,
6000 milligrams of oral chondroitin sulfate in June of 1966,
tapered to 1500 mg by December, 1966.
months following chondroitin: "very marked clinical
improvement; complete disappearance of angina chest pain;
began swimming, walking. Remarkable increase in vitality."
Heart attack (healed), general artery disease, high blood
pressure, prostate enlargement, "heart pounding"
and skipped heartbeats; weakness, shortness of breath on
exertion, loss of memory, insomnia, nervousness; blood pressure
treatments: Digitalis, blood pressure drugs, lecithin, vitamin
6000 milligrams of oral chondroitin sulfate in June of 1966,
tapered to 1500 mgs by Oct. 1966.
Sept. 1966 patient reported he "feels wonderful";
disappearance of fatigue, debility, nervousness, weakness
on exertion; no skipped heart beats; bushy hair growth on
head, black hair replacing white hair; cancellation of planned
recent experiences come to mind in regard to chondroitin
sulfate and post-heart attack patients.
man living in a remote part of eastern Washington State
was reported to have experienced crushing persistent chest
pain, with swelling of his ankles, evidence of heart failure
following a heart attack. The man was averse to seeking
medical treatment. He was advised to take 1500 milligrams
of chondroitin sulfate with other dietary supplements. Months
later he was finally coaxed to undergo examination by a
cardiologist who explained, by his past history, he had
experienced some sort of serious cardiac event, but that
there was no remaining evidence of the event.
another instance, a 64-year-old man, who had experienced
four prior heart attacks, which were evident on his electrocardiogram
(EKG), took 1500 milligrams of chondroitin sulfate for a
few months, then returned to a follow-up EKG in preparation
for hernia surgery. Surprisingly, his EKG showed no evidence
of a prior heart attack. The EKG technician thought his
name had mistakenly been marked on an EKG of a healthy patient,
so the EKG test was repeated, with the same result. This
man has no more chest pain and is bicycling and hiking at
a performance level uncharacteristic of a person his age.
heart is slow to heal following a heart attack. Cell renewal
is slow. Heart muscle tissue remains scarred (fibrotic).
The provision of supplemental chondroitin sulfate appears
to accelerate healing following a heart attack and would
be a simple and unproblematic approach to regaining heart
health following a heart attack. For the healthy, supplemental
chondroitin sulfate would keep arterial plaque from developing
chondroitin also inhibits
arterial calcification and cholesterol
plaque as well as formation
of blood clots, it becomes a comprehensive plaque and
clot buster, proven in forgotten human studies. Chondroitin
sulfate alone should be preferred over glucosamine, which
requires a number of nutritional precursors before it can
be converted to chondroitin.
1973 May; 24(5):26987
heart disease: reduction of death rate by chondroitin
sulfate A. Morrison
1972 Dec 15; 28(12):14101
of naturally occurring coronary atherosclerosis in squirrel
monkeys treated with chondroitin sulfate A. Morrison
1972 JulAug; 16(1):10518.
of vascular lesions by chondroitin sulfate A in the
coronary artery and aorta of rats induced by a hypervitaminosis
D, cholesterol-containing diet. Morrison
1971 Mar; 22(3):16574
of ischemic coronary heart disease by chondroitin sulfate
A. Morrison LM.
Medicine Surgery. 1970; 28(2):18893
of the plasma thrombus formation time of dogs administered
chondroitin sulfates A and C. Morrison
Am Geriatric Society 1969 Oct; 17(10):91323
of ischemic heart disease to chondroitin sulfate-A.
Medicine Surgery. 1969; 27(3):27889
prevention of coronary arteriosclerotic heart disease
with chondroitin sulfate A: preliminary report. Morrison
JJ Jr, Schjeide OA, Patek
American Geriatric Society. 1968 Jul; 16(7):77985
of coronary arteriosclerotic heart disease with chondroitin
sulfate-A: preliminary report. Morrison
Medicine Surgery. 1967; 25(1):6171
of atherosclerosis with acid mucopolysaccharides. Morrison
JJ Jr, Murata
Research. 1966 Aug; 19(2):35863
of atherosclerosis in sub-human primates by chondroitin
sulfate A. Morrison LM, Murata
JJ Jr, Schjeide